Health Technology

All signs point to Aruna Biomedical, an Athens, Georgia-based maker of neural stem cell kits for researchers, remaining in Georgia despite efforts to lure it to Wisconsin. Dick Leazer, a principal in Wisconsin Investment Partners, believes the company has found the equity investment it needs...

When it comes to approving drugs in the United States, should safety be the primary endpoint for approval? In this second part of a MedTech Futures column on the FDA approval process, Dr. Ogan Gurel calls for the FDA to refocus its primary mission on...

Madison Area Technical College will host a technology experience for girls June 26-28. Forty-five girls in grades six through nine are expected to attend the event, which is sponsored by area technology companies. ...

The recent controversy over GlaxoSmithKline's diabetes drug Avandia has once again put the Food & Drug Administration in Congressional crosshairs. In Part I of a MedTech Futures column on the FDA approval process, Dr. Ogan Gurel suggests that safety-minded FDA employees be taken more seriously. ...

Angel investments in early-stage Wisconsin companies topped $100 million last year, but the average size of the Wisconsin angel deal - $2.2 million - has at least one observer wondering if some angels are taking the place of venture investors in follow-up rounds. Just over...

In its first financial report since becoming a publicly traded company, Madison's TomoTherapy reported surging revenues and a hefty net loss that was due in part to a temporary accounting adjustment. The report does not include $186 million in net proceeds from its recent IPO,...

Cutting taxes always works to stimulate economic growth, according to State Senator Ted Kanavas, and the Wisconsin Act 255 tax credit program is further proof. In this guest column, Kanavas implores the Legislature to keep that lesson in mind as a proposed expansion to the...